NetTargets Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

NetTargets General Information

Description

Developer of a drug discovery platform designed to discover novel drug targets. The company's platform uses systems biology and machine learning to compile chemical, biological, experimental, and clinical data, enabling pharmaceutical companies to discover new drugs more efficiently and effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 104 Daeduk University Business Incubator
  • 68 Gajeongbuk-ro Yuseong-gu
  • Daejeon, 34141
  • South Korea
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 104 Daeduk University Business Incubator
  • 68 Gajeongbuk-ro Yuseong-gu
  • Daejeon, 34141
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NetTargets Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 27-Jun-2021 Completed Generating Revenue
2. Seed Round 15-Apr-2020 $501.82 Completed Startup
1. Accelerator/Incubator 01-Oct-2019 $501.82 $501.82 Completed Startup
To view NetTargets’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NetTargets Patents

NetTargets Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025249945-A1 Single-cell gene expression time-series simulation and ode-based immune target prediction method Pending 30-May-2024
WO-2024219864-A1 Novel compound exhibiting setdb1 inhibitory activity, and use thereof Inactive 18-Apr-2023

NetTargets Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NetTargets Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
BS Investment Partners Venture Capital Minority
CKD Venture Capital Corporate Venture Capital Minority
DA Value Investment Growth/Expansion Minority
Friend Investment Partners (Seoul) Venture Capital Minority
GU Equity Partners (Korea) Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

NetTargets FAQs

  • When was NetTargets founded?

    NetTargets was founded in 2019.

  • Where is NetTargets headquartered?

    NetTargets is headquartered in Daejeon, South Korea.

  • What is the size of NetTargets?

    NetTargets has 21 total employees.

  • What industry is NetTargets in?

    NetTargets’s primary industry is Discovery Tools (Healthcare).

  • Is NetTargets a private or public company?

    NetTargets is a Private company.

  • What is NetTargets’s current revenue?

    The current revenue for NetTargets is .

  • How much funding has NetTargets raised over time?

    NetTargets has raised $7.13M.

  • Who are NetTargets’s investors?

    BS Investment Partners, CKD Venture Capital, DA Value Investment, Friend Investment Partners (Seoul), and GU Equity Partners (Korea) are 5 of 10 investors who have invested in NetTargets.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process